40 GENES FOUNDi

Show / hide columns »

XML | RDF | TAB | Page of 1

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KCNA1Potassium channel, voltage gated shaker related subfamily A, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium channel, voltage gated shaker related subfamily A, member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Cytosol
Tissue enhanced
KCNA2Potassium channel, voltage gated shaker related subfamily A, member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium channel, voltage gated shaker related subfamily A, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium channel, voltage gated shaker related subfamily A, member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium channel, voltage gated shaker related subfamily A, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNA6Potassium voltage-gated channel subfamily A member 6 FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNA7Potassium channel, voltage gated shaker related subfamily A, member 7FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNB1Potassium channel, voltage gated Shab related subfamily B, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB2Potassium channel, voltage gated Shab related subfamily B, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoli
Plasma membrane
Midbody
Tissue enhanced
KCNC1Potassium channel, voltage gated Shaw related subfamily C, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleus
Nuclear membrane
Vesicles
Cytosol
Tissue enriched
KCNC2Potassium channel, voltage gated Shaw related subfamily C, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Plasma membrane
Cytosol
Tissue enriched
KCNC3Potassium channel, voltage gated Shaw related subfamily C, member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC4Potassium channel, voltage gated Shaw related subfamily C, member 4Predicted membrane proteins
Voltage-gated ion channels
Nucleoli
Cytosol
Mixed
KCND1Potassium channel, voltage gated Shal related subfamily D, member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
NucleusMixed
KCND2Potassium channel, voltage gated Shal related subfamily D, member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium channel, voltage gated Shal related subfamily D, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNF1Potassium channel, voltage gated modifier subfamily F, member 1Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Golgi apparatusTissue enriched
KCNG1Potassium channel, voltage gated modifier subfamily G, member 1Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
VesiclesTissue enhanced
KCNG2Potassium channel, voltage gated modifier subfamily G, member 2Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNG3Potassium channel, voltage gated modifier subfamily G, member 3Predicted membrane proteins
Voltage-gated ion channels
Cytoplasmic bodiesTissue enhanced
KCNG4Potassium channel, voltage gated modifier subfamily G, member 4Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNH1Potassium channel, voltage gated eag related subfamily H, member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesTissue enriched
KCNH2Potassium channel, voltage gated eag related subfamily H, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNH3Potassium channel, voltage gated eag related subfamily H, member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleus
Mitochondria
Group enriched
KCNH4Potassium channel, voltage gated eag related subfamily H, member 4Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNH5Potassium channel, voltage gated eag related subfamily H, member 5Predicted membrane proteins
Voltage-gated ion channels
Microtubules
Mitotic spindle
Tissue enhanced
KCNH6Potassium channel, voltage gated eag related subfamily H, member 6Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNH7Potassium channel, voltage gated eag related subfamily H, member 7Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNH8Potassium channel, voltage gated eag related subfamily H, member 8Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium channel, voltage gated KQT-like subfamily Q, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium channel, voltage gated KQT-like subfamily Q, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KCNQ3Potassium channel, voltage gated KQT-like subfamily Q, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNQ4Potassium channel, voltage gated KQT-like subfamily Q, member 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNQ5Potassium channel, voltage gated KQT-like subfamily Q, member 5Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
VesiclesTissue enhanced
KCNS1Potassium voltage-gated channel, modifier subfamily S, member 1Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS2Potassium voltage-gated channel, modifier subfamily S, member 2Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNS3Potassium voltage-gated channel, modifier subfamily S, member 3Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Golgi apparatus
Plasma membrane
Cytosol
Tissue enhanced
KCNV1Potassium channel, voltage gated modifier subfamily V, member 1Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNV2Potassium channel, voltage gated modifier subfamily V, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched

Page of 1